XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statement of Changes in Equity - USD ($)
$ in Thousands
Total
Total Shareholders' Equity
Total Shareholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit and Cumulative Distributions
Accumulated Deficit and Cumulative Distributions
Cumulative Effect, Period of Adoption, Adjustment
Non-controlling Interests
Non-controlling Interests
Cumulative Effect, Period of Adoption, Adjustment
Total Equity, Excluding Redeemable Non Controlling Interest
Total Equity, Excluding Redeemable Non Controlling Interest
Cumulative Effect, Period of Adoption, Adjustment
Class S Common Shares
Common Stock
Class D Common Shares
Common Stock
Class I Common Shares
Common Stock
Beginning balance at Dec. 31, 2022   $ 736,083 $ (5,162)   $ 744,852 $ 3,678 $ (13,212) $ (5,162) $ 293,567 $ (1,995) $ 1,029,650 $ (7,157) $ 434 $ 14 $ 317
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Common shares issued   311,284     310,979           311,284   116 13 176
Offering costs   (9,595)     (9,595)           (9,595)        
Distribution reinvestment   6,480     6,475           6,480   3   2
Common share repurchases   (2,142)   $ (2,142) (2,140)           (2,142)   (2)    
Amortization of restricted share grants   37     37           37        
Net income $ 13,285 10,310         10,310   2,939   13,249        
Other comprehensive income (loss) (7,350) (5,745)       (5,745)     (1,604)   (7,349)        
Distributions declared on common shares   (16,079)         (16,079)       (16,079)        
Redeemable common share measurement adjustment   3     3           3        
Contributions from non-controlling interests                 29   29        
Distributions to and redemptions of non-controlling interests                 (25,917)   (25,917)        
Redeemable non-controlling interests measurement adjustment   (15)     (15)           (15)        
Reallocation between additional paid-in capital and non-controlling interests due to changes in ownership   (2,567)     (2,567)       2,530   (37)        
Ending balance at Mar. 31, 2023   1,022,892     1,048,029 (2,067) (24,143)   269,549   1,292,441   551 27 495
Beginning balance at Dec. 31, 2023 2,077,466 1,820,751     1,948,355 3,052 (132,638)   256,715   2,077,466   921 45 1,016
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Common shares issued   532,420     531,896           532,420   251 5 268
Offering costs   (14,080)     (14,080)           (14,080)        
Distribution reinvestment   17,310     17,293           17,310   8   9
Common share repurchases   (16,887)   $ (16,887) (16,871)           (16,887)   (8)   (8)
Converted common shares   0     1           0     (47) 46
Amortization of restricted share grants   (334)     (334)           (334)        
Net income 15,814 14,131         14,131   1,579   15,710        
Other comprehensive income (loss) 14,600 13,035       13,035     1,469   14,504        
Distributions declared on common shares   (39,209)         (39,209)       (39,209)        
Redeemable common share measurement adjustment   (15)     (15)           (15)        
Contributions from non-controlling interests                 38   38        
Distributions to and redemptions of non-controlling interests                 (8,147)   (8,147)        
Redeemable non-controlling interests measurement adjustment   (125)     (125)           (125)        
Reallocation between additional paid-in capital and non-controlling interests due to changes in ownership   (5,102)     (5,102)       4,790   (312)        
Ending balance at Mar. 31, 2024 $ 2,578,339 $ 2,321,895     $ 2,461,018 $ 16,087 $ (157,716)   $ 256,444   $ 2,578,339   $ 1,172 $ 3 $ 1,331